Clinical Trials

Showing 401 - 420 of 519 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of Cabozantinib in Women with Hormone Receptor-Positive Breast Cancer that Spread to the Bone
[Protocol 12-091]
Fornier, Monica
  • Breast Cancer
A Phase I/II Study of ASP2215 in Patients with Recurrent or Persistent Acute Myeloid Leukemia
[Protocol 14-196]
Feller, Faye
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
Cabozantinib versus Sunitinib for Treating Previously Untreated Locally Advanced or Metastatic Renal Cell Cancer
[Protocol 14-072]
Feldman, Darren
  • Kidney Cancer
A Phase II Study of Paclitaxel/Ifosfamide/Cisplatin versus Bleomycin/Etoposide/Cisplatin in Patients Newly Diagnosed with Advanced Germ Cell Tumors
[Protocol 13-074]
Feldman, Darren
  • Germ Cell Tumors
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226]
Feldman, Darren
  • Kidney Cancer
Coping with Cancer II
[Protocol 14-048]
Epstein, Andrew
  • Colorectal Cancer
    • Colon Cancer
    • Rectal Cancer
  • Hepatobiliary
    • Liver Cancer
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
    • Pancreatic Cancer
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041]
Eastham, James
  • Prostate Cancer
    • Localized Disease
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-198]
Dunkel, Ira
  • Melanoma
A Phase II Study of Response-Based Radiation Therapy for Patients with Localized Germ Cell Tumors of the Central Nervous System
[Protocol 12-243]
Dunkel, Ira
  • Germ Cell Tumors
  • Pediatric Brain Tumors
    • CNS Cancer
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
Relapsed/Refractory
[Protocol 12-151]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma
[Protocol 08-072]
Dunkel, Ira
  • Retinoblastoma
A Phase II Study of Ipilimumab in Children and Adolescents with Stage III/IV Inoperable Melanoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-043]
Dunkel, Ira
  • Melanoma
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer (ALTE07C1)
Newly Diagnosed
[Protocol 12-241]
Dunkel, Ira
  • Survivorship
A Phase I/IIA Study of Dabrafenib in Children with Advanced BRAF Mutation-Positive Solid Tumors
[Protocol 13-016]
Dunkel, Ira
  • Melanoma
  • Pediatric Brain Tumors
  • Solid Tumors
A Phase Ib Study of Tremelimumab and MEDI4736 in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 13-197]
Drilon, Alexander
  • Lung Cancer, Non-Small Cell
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097]
Drilon, Alexander
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of Lurbinectedin plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 13-170]
Drilon, Alexander
  • Breast Cancer
  • Cervical Cancer
  • Germ Cell Tumors
  • Head & Neck Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Solid Tumors
  • Uterine (Endometrial) Cancer
A Phase I Study of RXDX-101 in Patients with Locally Advanced or Metastatic Cancers Containing Alternations in the TRKA, TRKB, TRKC, ROS1, or ALK Proteins
[Protocol 14-131]
Drilon, Alexander
  • Solid Tumors
A Phase I Study of SNX-5422 in Patients with Advanced Lung Cancer
[Protocol 13-230]
Drilon, Alexander
  • Lung Cancer, Non-Small Cell
  • Lung Cancer, Small Cell
A Phase I Study of TAS-119 plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 14-149]
Drilon, Alexander
  • Solid Tumors